Four-year Outcomes of Neoadjuvant Chemoimmunotherapy vs. Chemoradiotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Multicenter Real-World Study
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · e32
DOI: 10.1016/j.ijrobp.2026.06.723 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von X. Zheng und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zheng, X., Ge, H., Yang, S., Zhang, W., Wang, H., Wang, X., Liu, H., & Wang, X. (2026). Four-year Outcomes of Neoadjuvant Chemoimmunotherapy vs. Chemoradiotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Multicenter Real-World Study. International Journal of Radiation Oncology*Biology*Physics, 126(1), e32. https://doi.org/10.1016/j.ijrobp.2026.06.723
Vancouver
Zheng X, Ge H, Yang S, Zhang W, Wang H, Wang X, et al. Four-year Outcomes of Neoadjuvant Chemoimmunotherapy vs. Chemoradiotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Multicenter Real-World Study. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):e32. doi:10.1016/j.ijrobp.2026.06.723
BibTeX
@article{Zheng2026,
author = {Zheng, X. and Ge, H. and Yang, S. and Zhang, W. and Wang, H. and Wang, X. and Liu, H. and Wang, X.M.},
title = {Four-year Outcomes of Neoadjuvant Chemoimmunotherapy vs. Chemoradiotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Multicenter Real-World Study},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {e32},
doi = {10.1016/j.ijrobp.2026.06.723}
}
EUVIMED